Le Lézard
Classified in: Health, Science and technology
Subject: PLW

ALPINE BIO, MAKER OF NOBELL FOODS, SECURES 10TH U.S. PATENT, BOLSTERING ITS PLATFORM AND DEMONSTRATING ITS LEADERSHIP IN MOLECULAR FARMING


SAN FRANCISCO, April 16, 2024 /PRNewswire/ -- Alpine Bio, San Francisco-based biology design company leading the molecular farming movement and maker of Nobell Foods an animal-free dairy brand, announced today a newly-issued patent, Recombinant Milk Proteins and Food Compositions Comprising the Same.

This milestone represents a significant stride in making animal-free dairy more accessible and appealing to consumers. Pioneering a novel, innovative technology, Alpine Bio's team of scientists have overcome several technical challenges in order to recombinantly express casein in plants, the main protein in milk that is responsible for giving cheese its melt and stretch. Nobell Foods has been on a mission to unlock a new age of animal-free products where taste, quality, and affordability are widely accessible. With further advances in Alpine Bio's end-to-end platform for protein production, Nobell Foods is even closer to bringing animal-free cheese to the world.

"Today we celebrate the breakthroughs our company has made over the last few years to reimagine the future of food in a way that positively impacts the climate, agriculture and our food system at large," said Magi Richani, Alpine Bio founder and CEO. "This milestone not only reflects our strides in science-backed technology, but also brings us closer to delivering a sustainable and delicious product to market."

This tenth patent, which is focused on dairy food compositions containing plant-expressed recombinant casein proteins, showcases Alpine Bio's advancements in replicating the production of traditional animal-based dairy products in a plant system. Strengthening Alpine Bio's robust IP portfolio, this patent further demonstrates the company's novel approach to revolutionizing the future of food with cheese that is produced without animals.

"Cheese is one of the most loved foods in the modern diet, and yet it is one of the worst offenders in terms of its climate impact," said Chris Rivest, Breakthrough Energy Ventures. Magi and her team have developed a transformative way to produce dairy-identical proteins in plants to create stretchy, gooey, delicious cheese that consumers love, but made from plants?it is simply amazing."

The United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,952,606 on April 9, 2024, protecting Alpine Bio's milk protein production technology. This proprietary technology enables high and consistent production of milk proteins in plants, greatly outperforming first-generation expression of casein and making the resulting animal-free products more cost competitive against traditional dairy products. 

About Alpine Bio: Alpine Bio is a San Francisco-based biology design company accelerating the evolution of plants. The company's proprietary biomanufacturing platform harnesses plant intelligence to create highly efficient protein factories. Its first product is an animal-free Mozzarella cheese from Nobell Foods, planning to launch via tastings in 2025. Started by Magi Richani in 2016, Alpine Bio is transforming plants into the world's most efficient protein factories. For more information please visit LinkedIn and www.alpbio.com for updates.

About Nobell Foods: Nobell Foods is an animal-free dairy brand creating the world's first cheese from plant-grown casein. Nobell Foods is on a path to unlock a new age of animal-free products where taste, quality, and affordability are widely accessible. For more information please visit www.nobellfoods.com and follow us on Instagram for updates.

Contacts:
Maude Michel
[email protected]

SOURCE Nobell Foods


These press releases may also interest you

11 mai 2024
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

11 mai 2024
NUVISTA Mental Health proudly announces its participation as a Gold Sponsor for the 2024 Ontario First...

11 mai 2024
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...

11 mai 2024
Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSH&RC) joined the Gulf Creatives Conference (GCC) at Harvard 2024. The event, GCC at Harvard, is organized by The Diwan, an organization run by graduate students at...

11 mai 2024
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use across a range of infectious disease, oncology,...

11 mai 2024
Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in...



News published on and distributed by: